Results 141 to 150 of about 221,455 (333)

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

Journal of Clinical Oncology, 2019
PURPOSE The PRIMA study (ClinicalTrials.gov identifier: NCT00140582) established that 2 years of rituximab maintenance after first-line immunochemotherapy significantly improved progression-free survival (PFS) in patients with follicular lymphoma ...
E. Bachy, J. Seymour, P. Feugier, F. Offner, A. López-Guillermo, D. Belada, L. Xerri, J. Catalano, P. Brice, F. Lemonnier, Alejandro Martín, O. Casasnovas, L. Pedersen, V. Dorvaux, D. Simpson, S. Leppa, J. Gabarre, M. D. da Silva, S. Glaisner, L. Ysebaert, A. Vekhoff, T. Intragumtornchai, S. le Gouill, A. Lister, J. Estell, G. Milone, A. Sonet, J. Farhi, H. Zeuner, H. Tilly, G. Salles   +30 more
semanticscholar   +1 more source

Employment Trajectories of Patients With Systemic Lupus Erythematosus and Factors Driving Transitions Between States

Arthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) significantly impacts employment capacity. This study aimed to investigate the impact of burden of disease activity, damage, and treatment on employment outcomes and transitions in patients with SLE. Methods Using data from a single center, we analyzed employment transitions, adjusted mean disease activity ...
Javier Mencia‐Ledo, Zahi Touma, Laura Whittall Garcia, Dafna D. Gladman, Behdin Nowrouzi‐Kia   +4 more
wiley   +1 more source

Clinical Characteristics and Concordance of Anti‐MDA5 Antibodies: A Multicenter Australian Study

Arthritis Care &Research, EarlyView.
Objective In Australia, anti‐MDA5 antibodies are exclusively tested by a line immunoblot assay (LIA). The clinical concordance of an LIA‐positive anti‐MDA5 result is unclear. We aimed to describe the clinical features and determine the clinical concordance of patients with anti‐MDA5 antibodies. Methods Electronic records of a multisite cohort (patients
Syed B. Ali, Thomas Khoo, Keeran Shivakumar, Adam Caroll, Lauren Hender, Dimitra Beroukas, Kim Griggs, Celina Jin, Theo De Malmanche, Jessica Day, Gabor Major, Vidya Limaye   +11 more
wiley   +1 more source

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.

The Lancet Oncology, 2019
BACKGROUND The prognosis for primary CNS lymphoma has improved with the use of high-dose methotrexate-based chemotherapy, but patient outcomes remain poor.
J. Bromberg, S. Issa, K. Bakunina, M. Minnema, T. Seute, M. Durian, G. Cull, H. Schouten, W. Stevens, J. Zijlstra, J. Baars, M. Nijland, K. Mason, A. Beeker, M. J. van den Bent, M. Beijert, M. Gonzales, D. de Jong, J. Doorduijn   +18 more
semanticscholar   +1 more source

Effectiveness of rituximab in nephrotic syndrome treatment

, 2017
Idiopathic nephrotic syndrome (INS) is a common chronic illness characterized by massive proteinuria and hypo-albuminemia in children. Baseline treatment is 6 month-corticotherapy.
Katarzyna Popko, Elżbieta Kuźma-Mroczkowska, Elżbieta Górska   +2 more
core   +1 more source

Microvascular Damage Is Associated With Carotid Wall Structural Changes in Systemic Sclerosis: A Capillaroscopy and Ultrasound‐Based Observational Study

Arthritis Care &Research, EarlyView.
Objective Systemic sclerosis (SSc) is characterized by cardiovascular risk excess not fully explained by traditional factors. Whether the severity of microvascular damage correlates with structural subclinical atherosclerosis remains unclear. We investigated the relationship between nailfold videocapillaroscopy (NVC) abnormalities and carotid ...
Eugenio Capparelli, Luca Clerici, Francesco Lapia, Giusy C. Moltisanti, Eleonora Zaccara, Greta Pellegrino, Daniela Bompane, Francesca Capelli, Letizia Ferrami, Laura Castelnovo, Antonio Tamburello, Maria Sole Chimenti, Paola Faggioli, Antonino Mazzone   +13 more
wiley   +1 more source

Prevalence of Dietary Supplement Use and Potential Medication Interactions Among Adults With Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to characterize the prevalence and correlates of dietary supplement use, identify commonly used supplements, and evaluate potential supplement–medication interactions among adults with systemic lupus erythematosus (SLE).
Sarah L. Patterson, Russell Ellyson, Jessica Fitzpatrick, Ghizlane Yaakoubi, Bradley Pearce, S. Sam Lim, Jinoos Yazdany, Laura C. Plantinga   +7 more
wiley   +1 more source

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.

The Lancet, 2019
BACKGROUND Six cycles of R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) are the standard treatment for aggressive B-cell non-Hodgkin lymphoma.
V. Poeschel, G. Held, M. Ziepert, M. Witzens-Harig, H. Holte, L. Thurner, P. Borchmann, A. Viardot, M. Soekler, U. Keller, C. Schmidt, L. Truemper, R. Mahlberg, R. Marks, H. Hoeffkes, B. Metzner, J. Dierlamm, N. Frickhofen, M. Haenel, A. Neubauer, M. Kneba, F. Merli, A. Tucci, P. de Nully Brown, M. Federico, E. Lengfelder, A. Di Rocco, R. Trappe, A. Rosenwald, C. Berdel, Martin Maisenhoelder, O. Shpilberg, Josif Amam, K. Christofyllakis, F. Hartmann, N. Murawski, S. Stilgenbauer, M. Nickelsen, G. Wulf, B. Glass, N. Schmitz, B. Altmann, M. Loeffler, M. Pfreundschuh   +43 more
semanticscholar   +1 more source

Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma? [PDF]

, 2020
Duodenal follicular lymphoma (DFL) is a specific variant of FL, predominantly localized in the second portion of the duodenum and often represents an incidental finding, even if some cases can present with abdominal pain.
Mecacci, B, Bocchia, M, Fabbri, A, Cencini, E   +3 more
core   +1 more source

Rituximab for TTP [PDF]

American Journal of Hematology, 2005
Sarah M, Scott, Zbigniew M, Szczepiorkowski   +1 more
openaire   +2 more sources